Healing and repair

KPV

KPV is in limbo: it is not approved, and it is on neither FDA list for compounding, so no pharmacy may lawfully make it. The evidence grade is animal-only. No study has tested it in people, so nobody knows if it helps or how safe it is.

limbochecked Evidence grade animal-only · our assessmentVerified

This page has not been individually reviewed by a clinician.

Fact sheet · 5 facts

every row cites its source and its date
FactValueTierCheckedSource
Also calledlysine-proline-valine, KPV free base, KPV acetateprimaryfda.gov
Classhealing-and-repairprimaryfda.gov
Regulatory statuslimboprimaryfda.gov
Status source read2026-10-23primaryfda.gov
Evidence gradeanimal-onlyour assessmentpeptideindex.ai

Short answer

KPV is in limbo: it is not approved, and it is on neither FDA list for compounding, so no pharmacy may lawfully make it. The evidence grade is animal-only. No study has tested it in people, so nobody knows if it helps or how safe it is.

Our assessment, drawn from the sources below.

What it is

KPV is a lab-made chain of three amino acids: lysine, proline and valine [6]. Amino acids are the building blocks of proteins. The same three sit at the end of alpha-MSH, a hormone the body makes [21]. Alpha-MSH calms swelling but also darkens the skin. Researchers point to KPV because it seems to calm swelling without that effect [21].

KPV is not part of any FDA-approved drug, and it has no official quality standard [6]. FDA says the name is used loosely. Sellers use it for more than one form, such as the plain peptide and its acetate salt [6]. Websites promote it for gut health, skin, wounds, the immune system and many other uses [6]. It is promoted as shots, pills, creams and nasal sprays, alone or mixed with other peptides [6].

What the evidence shows

Evidence grade: animal-only · our assessment

The evidence grade is animal-only: the studies that show an effect used mice, rabbits or cells, and FDA found no study of KPV in people [6]. The evidence for each way of taking it is different, so each is kept apart below.

In mice with a swollen belly lining, KPV given to the whole body cut the number of white blood cells that gathered there [14]. Another team found that KPV eased swelling in two mouse models of bowel disease [16].

By mouth: in mice with bowel swelling, KPV in drinking water eased the swelling [15]. A later team packed KPV into tiny coated particles. Fed to mice with colitis, the coated particles protected the gut lining better than uncoated ones [17]. On the eye: in rabbits whose eye surface was scraped, KPV drops helped it heal faster [18]. On the skin: in a lab test on donated human skin, KPV did not pass through the skin on its own [19]. FDA notes this could stop a cream from reaching the deeper skin [6].

Many papers cited for KPV studied alpha-MSH, the larger hormone, or changed forms of KPV [6] [21]. Those are different molecules. Their results are not evidence for KPV [6]. Two reviews call KPV a hopeful candidate for future skin and bowel treatments [20] [21]. One says studies in people are needed first [6] [20].

Known risks

  • FDA warns that a peptide like KPV may set off the immune system. Peptides can also clump together, which can make this worse [6].
  • FDA says the name KPV is used for more than one substance. A product sold as KPV may not hold the form a doctor ordered [6].
  • FDA found no test results for impurities, clumps or germs in KPV powder, so nobody knows how pure a product is [6].
  • FDA warns that shots made outside drug rules can carry germs or toxins straight into the body. That can put a life at risk [9].

What nobody knows yet

  • No study has tested KPV in people, so nobody knows if it helps any human illness [6].
  • Nobody knows what KPV does over time. No study has checked it for harm to organs, genes, unborn babies or for cancer [6].
  • Scientists do not know what KPV attaches to in the body. Studies suggest it does not use the same targets as the hormone it comes from [6] [14].
  • KPV barely gets through skin on its own, so nobody knows if a cream would reach a wound [19].

Legitimate ways to get it

There is no legal way to get KPV in the US today [6]. No approved drug contains it, here or in Europe [6]. A pharmacy may use a substance with no official quality standard only if it is in an approved drug or on the federal list. KPV is neither [3] [6]. That could change if FDA adds it by writing a rule after the committee vote [11].

FDA found no clinical study of KPV in people [6]. Any open trial would appear in the trials block below, with the date the official registry was last checked.

  • None

    There is no legal route to KPV in the US today. It is in no approved drug, has no official quality standard, and is not on the list pharmacies may use.

    fda.gov

Recruiting trials

A listing is not a recommendation. Trials have strict eligibility rules. Talk to your doctor and read the official record.

No open trials in the snapshot of .clinicaltrials.gov

How people are getting it anyway

This section describes what happens and is not a recommendation.

People who use KPV get it in three main ways [6] [23]. The first is online sellers that label peptides for research use only. FDA says that label does not make it legal to sell a drug meant for people [9] [13]. The second is pharmacies that make it even though it is not on the federal list [6]. FDA has warned a pharmacy for making drugs from substances that are not on the list [10]. The third is websites that link people to a prescriber and a pharmacy through an online visit [6].

In all three, nobody checks what is in the product the way FDA checks an approved drug. FDA found no test results for impurities or germs in KPV powder [6]. FDA found no reports of harm from KPV in its files. FDA says that does not show KPV is free of harm, because pharmacies seldom report problems [6]. So nobody knows how often harm happens.

  • Research use seller

    Sold online with a label saying it is for research use only and not for people.

    The lawFDA treats these products as unapproved new drugs when the seller's claims show they are meant for people, whatever the label says.fda.gov

    Documented riskFDA warns that unapproved shots can carry toxins or germs straight into the body and cause a life-threatening illness.fda.gov

    Documented riskFDA found no test results for impurities, clumps or germs in KPV powder.fda.gov

    Enforcement FDA warning letter to an online seller of research-use peptide shots. The letter did not name KPV.fda.gov

  • Compounding outside the rules

    Made by a pharmacy from bulk KPV powder, as shots, pills, creams or nasal sprays.

    The lawKPV has no official quality standard, is in no approved drug and is not on the federal list. A pharmacy that compounds it loses the legal exemptions for compounded drugs.fda.gov

    Documented riskFDA found no study of KPV in people by any route, so the safety of a compounded product is unknown.fda.gov

    Documented riskFDA says products sold under the name KPV can hold different forms, so a patient may get a different substance than the one prescribed.fda.gov

    Enforcement FDA warning letter to a Texas compounding pharmacy that made drugs from bulk substances not on the federal list. The letter did not name KPV.fda.gov

  • Telehealth

    Websites that offer KPV made by a compounding pharmacy after an online visit with a prescriber.

    The lawA prescription does not make compounded KPV lawful. It is still made from a substance that is not on the federal list.fda.gov

    Documented riskFDA found no human data on any product with KPV, including whether it sets off the immune system.fda.gov

Sources

  1. [1]FDA: bulk drug substances that may present significant safety risks, including those withdrawn from Category 2Regulatory · primary
  2. [2]FDA: bulk drug substances nominated under section 503A, list updated 14 May 2026Regulatory · primary
  3. [3]FDA: bulk drug substances used in compounding under section 503ARegulatory · primary
  4. [4]Federal Register: notice of the July 2026 Pharmacy Compounding Advisory Committee meetingRegulatory · primary
  5. [5]FDA: Pharmacy Compounding Advisory Committee meeting, 23 and 24 July 2026Regulatory · primary
  6. [6]FDA briefing document on KPV for the July 2026 committee meeting, 12 May 2026Regulatory · primary
  7. [7]FDA: questions put to the committee at the July 2026 meetingRegulatory · primary
  8. [8]FDA: presentations to the committee on 23 July 2026, including KPVRegulatory · primary
  9. [9]FDA warning letter to an online seller of research-use peptides, 24 August 2026Regulatory · primary
  10. [10]FDA warning letter to a compounding pharmacy that used bulk substances not on the list, 30 July 2019Regulatory · primary
  11. [11]McDermott Will & Schulte: what the July 2026 committee votes on peptides meanLegal analysis · legal-analysis
  12. [12]FDA Law Blog: the committee recommends four peptides for the 503A listLegal analysis · legal-analysis
  13. [13]Sheppard Mullin: FDA's peptide policy and its warning letters to peptide sellersLegal analysis · legal-analysis
  14. [14]KPV and alpha-MSH peptides in mice with inflammation of the belly lining, 2003Animal · peer-reviewed
  15. [15]KPV taken up by gut cells, and KPV by mouth in two mouse colitis models, 2008Animal · peer-reviewed
  16. [16]KPV in two mouse models of inflammatory bowel disease, 2008Animal · peer-reviewed
  17. [17]KPV in tiny particles given by mouth to mice with ulcerative colitis, 2017Animal · peer-reviewed
  18. [18]KPV eye drops and healing of the eye surface in rabbits, 2006Animal · peer-reviewed
  19. [19]Getting KPV through donated human skin in the lab, 2017In vitro · peer-reviewed
  20. [20]Review: melanocortin peptides, including KPV, as future wound treatments, 2019Reference · peer-reviewed
  21. [21]Review: alpha-MSH and related three-amino-acid peptides, including KPV, 2008Reference · peer-reviewed
  22. [22]STAT: FDA panel backs compounded BPC-157 and KPV peptidesReference · established-news
  23. [23]NBC News: FDA panel recommends easing peptide limits despite agency scientistsReference · established-news

Last verified · 5 facts · 7 sources

Primary source: https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks

Machine readers: JSON · Markdown · Status history: Change log

Information, not medical advice.

Status alerts

Get status alerts for KPV

No alert has been sent yet. Until alerts begin, the confirmation is the only email you will get.

Sent by Migration Group, LLC. No account and no marketing. Unsubscribe at any time.